These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 18922426

  • 1. A randomized trial evaluating different modalities of levosimendan administration in cardiac surgery patients with myocardial dysfunction.
    De Hert SG, Lorsomradee S, vanden Eede H, Cromheecke S, Van der Linden PJ.
    J Cardiothorac Vasc Anesth; 2008 Oct; 22(5):699-705. PubMed ID: 18922426
    [Abstract] [Full Text] [Related]

  • 2. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
    De Hert SG, Lorsomradee S, Cromheecke S, Van der Linden PJ.
    Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
    [Abstract] [Full Text] [Related]

  • 3. Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trial.
    Mehta RH, Van Diepen S, Meza J, Bokesch P, Leimberger JD, Tourt-Uhlig S, Swartz M, Parrotta J, Jankowich R, Hay D, Harrison RW, Fremes S, Goodman SG, Luber J, Toller W, Heringlake M, Anstrom KJ, Levy JH, Harrington RA, Alexander JH, LEVO-CTS Investigators.
    Am Heart J; 2016 Dec; 182():62-71. PubMed ID: 27914501
    [Abstract] [Full Text] [Related]

  • 4. A Randomized Blinded Study of the Left Ventricular Myocardial Performance Index Comparing Epinephrine to Levosimendan following Cardiopulmonary Bypass.
    Salgado Filho MF, Barral M, Barrucand L, Cavalcanti IL, Verçosa N.
    PLoS One; 2015 Dec; 10(12):e0143315. PubMed ID: 26655803
    [Abstract] [Full Text] [Related]

  • 5. Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function.
    Eriksson HI, Jalonen JR, Heikkinen LO, Kivikko M, Laine M, Leino KA, Kuitunen AH, Kuttila KT, Peräkylä TK, Sarapohja T, Suojaranta-Ylinen RT, Valtonen M, Salmenperä MT.
    Ann Thorac Surg; 2009 Feb; 87(2):448-54. PubMed ID: 19161758
    [Abstract] [Full Text] [Related]

  • 6. Levosimendan in congenital cardiac surgery: a randomized, double-blind clinical trial.
    Momeni M, Rubay J, Matta A, Rennotte MT, Veyckemans F, Poncelet AJ, Clement de Clety S, Anslot C, Joomye R, Detaille T.
    J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):419-24. PubMed ID: 20829069
    [Abstract] [Full Text] [Related]

  • 7. Levosimendan vs. intra-aortic balloon pump in high-risk cardiac surgery.
    Lomivorotov VV, Cherniavskiy AM, Boboshko VA, Kornilov IA, Lomivorotov VN, Karaskov AM.
    Asian Cardiovasc Thorac Ann; 2011 Apr; 19(2):154-9. PubMed ID: 21471262
    [Abstract] [Full Text] [Related]

  • 8. Levosimendan for weaning from cardiopulmonary bypass after coronary artery bypass grafting.
    Akgul A, Mavioglu L, Katircioglu SF, Pac M, Cobanoglu A.
    Heart Lung Circ; 2006 Oct; 15(5):320-4. PubMed ID: 16860605
    [Abstract] [Full Text] [Related]

  • 9. Effect of Levosimendan on Low Cardiac Output Syndrome in Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: The LICORN Randomized Clinical Trial.
    Cholley B, Caruba T, Grosjean S, Amour J, Ouattara A, Villacorta J, Miguet B, Guinet P, Lévy F, Squara P, Aït Hamou N, Carillion A, Boyer J, Boughenou MF, Rosier S, Robin E, Radutoiu M, Durand M, Guidon C, Desebbe O, Charles-Nelson A, Menasché P, Rozec B, Girard C, Fellahi JL, Pirracchio R, Chatellier G, -.
    JAMA; 2017 Aug 08; 318(6):548-556. PubMed ID: 28787507
    [Abstract] [Full Text] [Related]

  • 10. Prophylactic treatment with levosimendan: a retrospective matched-control study of patients with reduced left ventricular function.
    Kolseth SM, Nordhaug DO, Stenseth R, Sellevold O, Kirkeby-Garstad I, Wahba A.
    Eur J Cardiothorac Surg; 2009 Dec 08; 36(6):1024-30. PubMed ID: 19592266
    [Abstract] [Full Text] [Related]

  • 11. Comparative Effect of Levosimendan and Milrinone in Cardiac Surgery Patients With Pulmonary Hypertension and Left Ventricular Dysfunction.
    Mishra A, Kumar B, Dutta V, Arya VK, Mishra AK.
    J Cardiothorac Vasc Anesth; 2016 Jun 08; 30(3):639-46. PubMed ID: 27321790
    [Abstract] [Full Text] [Related]

  • 12. Levosimendan increases bleeding risk after heart valve surgery: a retrospective analysis of a randomized trial.
    Lahtinen P, Pitkänen O, Musialowicz T.
    J Cardiothorac Vasc Anesth; 2014 Oct 08; 28(5):1238-42. PubMed ID: 25281042
    [Abstract] [Full Text] [Related]

  • 13. Levosimendan or milrinone in the type 2 diabetic patient with low ejection fraction undergoing elective coronary artery surgery.
    Al-Shawaf E, Ayed A, Vislocky I, Radomir B, Dehrab N, Tarazi R.
    J Cardiothorac Vasc Anesth; 2006 Jun 08; 20(3):353-7. PubMed ID: 16750735
    [Abstract] [Full Text] [Related]

  • 14. Effects of levosimendan on left ventricular relaxation and early filling at maintained preload and afterload conditions after aortic valve replacement for aortic stenosis.
    Jörgensen K, Bech-Hanssen O, Houltz E, Ricksten SE.
    Circulation; 2008 Feb 26; 117(8):1075-81. PubMed ID: 18268152
    [Abstract] [Full Text] [Related]

  • 15. Preoperative levosimendan infusion in combined aortic valve and coronary bypass surgery.
    Leppikangas H, Järvelä K, Sisto T, Maaranen P, Virtanen M, Lehto P, Karlsson S, Kööbi T, Lindgren L.
    Br J Anaesth; 2011 Mar 26; 106(3):298-304. PubMed ID: 21258075
    [Abstract] [Full Text] [Related]

  • 16. Levosimendan in aortic valve surgery: cardiac performance and recovery.
    Järvelä K, Maaranen P, Sisto T, Ruokonen E.
    J Cardiothorac Vasc Anesth; 2008 Oct 26; 22(5):693-8. PubMed ID: 18922425
    [Abstract] [Full Text] [Related]

  • 17. Levosimendan versus an intra-aortic balloon pump in high-risk cardiac patients.
    Lomivorotov VV, Boboshko VA, Efremov SM, Kornilov IA, Chernyavskiy AM, Lomivorotov VN, Knazkova LG, Karaskov AM.
    J Cardiothorac Vasc Anesth; 2012 Aug 26; 26(4):596-603. PubMed ID: 22051419
    [Abstract] [Full Text] [Related]

  • 18. [A COMPARISON OF TWO APPROACHES FOR INTRAOPERATIVE LEVOSIMENDAN ADMINISTRATION IN CARDIAC SURGICAL PATIENTS WITH SEVERE LEFT VENTRICLE DYSFUNCTION.].
    Pasyuga VV, Belov SI, Yusupova ES, Adzhigaliev RR, Berezhnoy SA, Panov OS, Tarasov DG, Yavorovsky AG.
    Anesteziol Reanimatol; 2016 Sep 26; 61(5):334-338. PubMed ID: 29489098
    [Abstract] [Full Text] [Related]

  • 19. Levosimendan reduces heart failure after cardiac surgery: a prospective, randomized, placebo-controlled trial.
    Lahtinen P, Pitkänen O, Pölönen P, Turpeinen A, Kiviniemi V, Uusaro A.
    Crit Care Med; 2011 Oct 26; 39(10):2263-70. PubMed ID: 21666445
    [Abstract] [Full Text] [Related]

  • 20. Levosimendan enhances cardiac performance after cardiopulmonary bypass: a prospective, randomized placebo-controlled trial.
    Nijhawan N, Nicolosi AC, Montgomery MW, Aggarwal A, Pagel PS, Warltier DC.
    J Cardiovasc Pharmacol; 1999 Aug 26; 34(2):219-28. PubMed ID: 10445673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.